PARACRINE INTERACTIONS IN PROLACTIN SECRETION
PARACRINE INTERACTIONS IN PROLACTIN SECRETION
批准号:
6824559
负责人:
GIRISH V SHAH
金额:
$7.55万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-05-01 至 2005-08-31
关键词:
calcitonin cell type genetically modified animals hormone regulation /control mechanism immunocytochemistry laboratory mouse laboratory rat mixed tissue /cell culture neuroendocrine system nucleic acid probes paracrine peptide hormone biosynthesis pituitary gland pituitary gonadal axis prolactin prolactin releasing /inhibiting factor sex hormones
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Well-defined distribution of various pituitary cells types in the
anterior pituitary (AP) gland suggest that Cell-to-Cell interactions play
an important role in the development, function and proliferation of AP
cells. Previous studies from this laboratory have shown that calcitonin-
like immunoreactive peptide (pit-CT) is synthesized and secreted by
cultured AP cells. It may affect lactotrope function because synthetic
sCT is a potent inhibitor of PRL secretion and PRL gene transcription.
Our recent studies have used immunohistological, cell culture and
molecular approaches to demonstrate that putative pit-CT mRNA and pit-CT
IR peptide is selectively expressed by gonadotropes and RC4B cells (tumor
cells of gonadotropelineage), and not by alphaT-3, GH3 or AT20 cells.
Temporally, pit-CT gene expression is initiated subsequent to, and not
prior to, the expression of LH Beta-subunits because pit-CT mRNA could
not be detected in alphaT-3 cells or fetal AP gland (embryonic day 19),
but could be detected in the AP gland of day 20 fetal age. The studies
in adult AP glands have shown that pit-CT IR gonadotropes were surrounded
by cup-shaped lactotropes, suggesting a role for pit-CT in juxtacrine
inhibition of lactotrope function. Physiological significance of pit-CT
action was demonstrated by the findings that passive immunization of pit-
CT with anti-sCT serum caused a dramatic increase in PRL secretion under
in vitro and in vivo conditions. Pit-CT IR content of the AP gland varied
significantly in various physiological conditions. Three days of E2
treatment caused a nine-fold decline in putative pit-CT mRNA abundance
and also caused four-fold decrease in pit-CT IR concentrations. In
contrast, ovariectomy induced a three-fold increase in pit-CT IR content.
Thus, pit-CT is a novel, physiologically relevant, gonadotrope-derived
inhibitor of lactotrope function. Since we have obtained a putative pit-
CT cDNA clone and the expression of putative pit-CT mRNA parallels the
expression of pit-CT IR, an objective of the present proposal is to
identify the precise role for pit-CT in maturation, function and
proliferation of lactotropes during development and adulthood. Specific
Aim of the proposal will develop RC4B-lactotrope co-culture model to test
the role of endogenous pit-CT in lactotrope function and proliferation.
Specific Aim 2 will study the consequence of gonadotrope-depletion or
pit-CT overexpression on lactotrope function. Specific Aim 3 and 4 will
further characterize the actions of gonadal steroids and other paracrine
and neuroendocrine factors on pit-CT expression. These studies will
provide new and significant findings towards the role of gonadotrope-
lactotrope interactions in pituitary function. These results will make
important contributions in understanding physiology of normal
reproduction and pathophysiology of aging.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Calcitonin inhibits prolactin gene transcription in rat pituitary cells.
降钙素抑制大鼠垂体细胞中催乳素基因的转录。
DOI:
10.1007/bf02935651
发表时间:
1995
期刊:
Endocrine
影响因子:
3.7
作者:
[Xue-Zhang,Q, Stanley,SM, Shah,GV]
通讯作者:
Shah,GV
Calcitonin is expressed in gonadotropes of the anterior pituitary gland: its possible role in paracrine regulation of lactotrope function.
降钙素在垂体前叶的促性腺激素中表达:其在催乳素功能的旁分泌调节中可能发挥作用。
DOI:
10.1677/joe.0.1710217
发表时间:
2001
期刊:
The Journal of endocrinology
影响因子:
--
作者:
[Ren,Y, Chien,J, Sun,YP, Shah,GV]
通讯作者:
Shah,GV
Calcitonin is a physiological inhibitor of prolactin secretion in ovariectomized female rats.
降钙素是去势雌性大鼠催乳素分泌的生理抑制剂。
DOI:
10.1210/endo.137.5.8612519
发表时间:
1996
期刊:
Endocrinology
影响因子:
4.8
作者:
[Shah,GV, Pedchenko,V, Stanley,S, Li,Z, Samson,WK]
通讯作者:
Samson,WK
Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3',5'-monophosphates and cytoplasmic Ca2+ transients.
降钙素通过受体介导的环腺苷 3,5-单磷酸和细胞质 Ca2 瞬变的增加来刺激人前列腺癌细胞的生长。
DOI:
10.1210/endo.134.2.8299557
发表时间:
1994
期刊:
Endocrinology
影响因子:
4.8
作者:
[Shah,GV, Rayford,W, Noble,MJ, Austenfeld,M, Weigel,J, Vamos,S, Mebust,WK]
通讯作者:
Mebust,WK
Calcitonin inhibits anterior pituitary cell proliferation in the adult female rats.
降钙素抑制成年雌性大鼠垂体前叶细胞增殖。
DOI:
10.1210/endo.140.9.6995
发表时间:
1999
期刊:
Endocrinology
影响因子:
4.8
作者:
[Shah,GV, Chien,J, Sun,YP, Puri,S, Ravindra,R]
通讯作者:
Ravindra,R
共 14 条
Calcitonin in Prostate Growth and Neplasia
-
批准号:8193255
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2001
-
负责人:GIRISH V SHAH
-
依托单位:
Calcitonin in Prostate Growth and Neoplasia
-
批准号:6801789
-
项目类别:
-
资助金额:$16.88万
-
财政年份:2001
-
负责人:GIRISH V SHAH
-
依托单位:
Calcitonin in Prostate Growth and Neoplasia
-
批准号:6652076
-
项目类别:
-
资助金额:$16.88万
-
财政年份:2001
-
负责人:GIRISH V SHAH
-
依托单位:
Calcitonin in Prostate Growth and Neplasia
-
批准号:8471538
-
项目类别:
-
资助金额:$16.94万
-
财政年份:2001
-
负责人:GIRISH V SHAH
-
依托单位:
Calcitonin in Prostate Growth and Neplasia
-
批准号:7737843
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2001
-
负责人:GIRISH V SHAH
-
依托单位:
Calcitonin in Prostate Growth and Neoplasia
-
批准号:7622909
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2001
-
负责人:GIRISH V SHAH
-
依托单位:
Calcitonin in Prostate Growth and Neplasia
-
批准号:7847694
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2001
-
负责人:GIRISH V SHAH
-
依托单位:
Calcitonin in Prostate Growth and Neoplasia
-
批准号:6522953
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2001
-
负责人:GIRISH V SHAH
-
依托单位:
Calcitonin in Prostate Growth and Neoplasia
-
批准号:6442056
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2001
-
负责人:GIRISH V SHAH
-
依托单位:
PARACRINE INTERACTIONS IN PROLACTIN SECRETION
-
批准号:2905483
-
项目类别:
-
资助金额:$7.92万
-
财政年份:1992
-
负责人:GIRISH V SHAH
-
依托单位:
PARACRINE INTERACTIONS IN PROLACTIN SECRETION
-
批准号:3246597
-
项目类别:
-
资助金额:$8.39万
-
财政年份:1992
-
负责人:GIRISH V SHAH
-
依托单位:
PARACRINE INTERACTIONS IN PROLACTIN SECRETION
-
批准号:2016516
-
项目类别:
-
资助金额:$14.92万
-
财政年份:1992
-
负责人:GIRISH V SHAH
-
依托单位:
PARACRINE INTERACTIONS IN PROLACTIN SECRETION
-
批准号:3246598
-
项目类别:
-
资助金额:$9.54万
-
财政年份:1992
-
负责人:GIRISH V SHAH
-
依托单位:
PARACRINE INTERACTIONS IN PROLACTIN SECRETION
-
批准号:2144297
-
项目类别:
-
资助金额:$12.83万
-
财政年份:1992
-
负责人:GIRISH V SHAH
-
依托单位:
PARACRINE INTERACTIONS IN PROLACTIN SECRETION
-
批准号:2144296
-
项目类别:
-
资助金额:$12.89万
-
财政年份:1992
-
负责人:GIRISH V SHAH
-
依托单位:
PARACRINE INTERACTIONS IN PROLACTIN SECRETION
-
批准号:2518321
-
项目类别:
-
资助金额:$17.72万
-
财政年份:1992
-
负责人:GIRISH V SHAH
-
依托单位:
PARACRINE INTERACTIONS IN PROLACTIN SECRETION
-
批准号:2770408
-
项目类别:
-
资助金额:$18.3万
-
财政年份:1992
-
负责人:GIRISH V SHAH
-
依托单位:
海外基金